RYVAX Mutual Fund

NAV$285.21

Returns Overview

1 Month
-8.11%
3 Months
-4.69%
6 Months
+37.29%
YTD
+32.52%
1 Year
+71.77%
3 Years (annualized)
+12.41%
5 Years (annualized)
+10.78%
10 Years (annualized)
-3.39%

Risk Metrics (1-Year)

No risk data available for this Mutual Fund

Stress Test Scenarios

How would RYVAX have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

No data

3 Months Performance

No data

6 Months Performance

No data

1 Year Performance

No data

Benchmark & Peers

Benchmark
S&P 500 Index(SPX)
This Mutual Fund (YTD)
+32.52%
Peer Avg (YTD)
+14.02%
vs Peers
+18.49%

RYVAX Mutual Fund Performance

RYVAX performance across multiple time periods: 1-month -8.11%, YTD 32.52%, 1-year 71.77%, 3-year 12.41%, 5-year 10.78%, 10-year -3.39%.

RYVAX returns outperform the peer average of 14.02% YTD. With an expense ratio of 1.63%, investors should weigh costs against performance when evaluating this mutual fund.

RYVAX performance comparison shows side-by-side returns with another fund. RYVAX alternatives are available in the Mutual Fund Screener.